highlight aao annual meet
recent attend american academi orthopaed surgeon
aao annual meet new orlean sever takeaway
convers industri contact confer outsid well-
attend investor event booth tour host publicly-held orthoped
compani highlight remain takeaway
bodi research note
contact think could see above-norm salesforc turnov later
year non-compet agreement end head former zimmer
biomet distributor elect retain merg two
compani sale organ contact believ former zimmer
biomet distributor may success hire former sale
repres away join compet firm given
prior relationship individu zbh continu difficulti
product suppli product line gap knee busi
convers industri contact suggest hip knee
implant market trend littl soft first two month year
point think current hip knee implant organ
growth estim may littl high
compani standpoint contact indic syk knee busi
remain strong overal expect syk knee organ growth
look similar adjust one less sale day year-over-year
although comment expect launch date next-
gener mako robot surgeri system contact continu suggest
readi launch end includ shoulder ankl
head year aao annual meet expect market share
dynam larg hip knee implant compani look similar
robust market share gain slightli market-level growth
snn modestli market-level growth depuy continu soft
result follow academi meet think assumpt
look direct correct anyth felt littl pessimist
zbh outlook modestli optimist syk prospect
convers industri contact
import pleas read disclosur disclaim page report
recent attend american academi orthopaed surgeon aao annual meet new orlean
opportun speak industri contact tour aao exhibit hall floor key
takeaway aao annual meet present research note
hip knee implant market
base convers industri contact believ hip knee implant market
trend littl soft first two month year gener contact suggest
domest joint replac market growth slower year-over-year basi
roughli year-over-year aid part procedur southeast portion
countri shift result hurrican activ march also one less
busi day year-over-year due time friday holiday april last year versu march
year overal base feedback receiv holiday shift think current
 hip knee implant organ growth estim may littl high said march
import month quarter procedur standpoint wait result
orthoped practic survey make chang forecast
head year aao annual meet expect market share dynam larg hip
knee implant compani look similar robust market share gain slightli
market-level growth snn led favor result knee modestli market-level growth
depuy driven weak knee continu soft result follow academi
meet think assumpt look direct correct anyth felt littl
pessimist zbh outlook modestli optimist syk prospect
convers industri contact
world-wide hip knee implant market mix price analysisnorthcoast researchhip knee knee market hip market knee hip knee hip knee hip knee hip knee hip compani report northcoast research estim
zbh new ceo bryan hanson clear suggest take time compani return
market growth level hip knee replac busi due product suppli issu relat
requir remedi effort legaci biomet warsaw manufactur facil product line gap
cementless knee robot knee replac divis zbh earn call suggest
expect gradual recoveri year aao meet mention two-year path
return compani combin hip knee replac busi market growth level
investor expect near-term recoveri zbh joint replac organ growth
think also like anticip new headwind along path stabil compani joint
replac market share along line came away aao annual meet feel
though could face new third growth headwind joint reconstruct busi year
above-norm sale forc turnov specif contact indic non-compet agreement
expir year former princip legaci zimmer biomet distributor elect
retain merg two compani sale organ would expect mani
individu join zbh competitor year non-compet agreement expir moreov
believ may success hire former sale repres away
join compet firm given prior relationship individu zbh continu difficulti
product suppli product line gap knee busi think bryan hanson effort
win disenfranchis sale rep help limit number defect worri could
disrupt expect point note indic sale rep turnov
remain normal level past five quarter product suppli issu bryan
hanson suggest aao meet thought would crazi sale rep leav
compani get closer fix suppli problem address portfolio gap
clear believ current hurt above-norm sale forc turnov howev
worri issu could becom new headwind compani
meet investor aao confer bryan hanson suggest believ
could deliv sustain mid-single-digit organ growth current busi mix
indic first focu get growth rate deserv exist product categori
look activ portfolio manag one except strategi appear zbh
dental busi compani appear look sell base report wall street
world-wide hip/kne implant market market share analysisnorthcoast researchmarket depuy compani report northcoast research estim journal find deal like would guess sell dental busi use
proce pay debt
regard portfolio gap remain track gener launch cementless version
persona knee system obtain fda clearanc persona trabecular metal tibial compon
late januari compani current conduct limit releas product build toward
full launch note earlier version persona trabecular metal tibial base plate remov
market three year ago compon sit optim compani also
made chang instrument new version persona trabecular metal tibial
similar cementless knee appear target limit launch total knee
replac applic rosa robot surgeri system compani prepar investor
possibl launch could delay quarter two given realiti frequent
delay orthoped product rollout approach launch fact frozen design
product bode well likelihood introduc time relat competit product
repres emphas potenti advantag term time landmark acquisit
rosa system minut second accord versu mako closer minut accord
regard cut tool rosa would comment say burr
like snn use navio regard system cost said fundament implant
compani creativ way hospit acquir rosa way support
implant partnership beyond total knee replac suggest partial knee would next
joint reconstruct applic rosa compani also plan reintroduc rosa spine
procedur note rosa indic use placement pedicl screw lumbar
spine case util posterior approach howev held market product
indic make chang system
overal clearli play catch-up robot seem eager competit respons
total knee sooner rather later two-year head start mako total knee
applic time zbh system enter limit launch much along path
document potenti advantag product patient satisfact outcom data
outsid hip knee replac key focu aao exhibit hall booth
launch sidu stemless shoulder system second product obtain fda clearanc
categori follow wmgi simplic rel simplic see advantag sidu regard
bone preserv eas use system instrument moreov given less
extens instrument need sidu abl manufactur instrument set
plan launch one month result rel fast domest roll-out
product within market see opportun earli win surgeon use mostli
product use simplic stemless shoulder system avail
time think stemless shoulder could repres similar percent shoulder market
europ european market year follow launch
within broader sport medicin surgic extrem trauma busi believ
product suppli issu account entireti under-perform rel market
compani believ meaning product gap segment follow launch
sidu
suggest move fast furiou certain high earli return project
implement low cost specif compani expect execut project
chang incent focu product compani suppli mention one
project within initi
suggest postpon certain elect procedur earli unit kingdom
expect reduc organ growth rate roughli bp compani sure whether
issu enough drive neg emea organ growth busi
worth snn call elect procedur postpon littl wors prior year
meaning differ
research suggest organ growth overal hip knee replac market
littl softer start year contact indic syk knee busi remain strong overal
expect syk knee organ growth look similar adjust one less sale day year-
over-year quarter
feedback heard regard syk mako total knee applic aao meet
posit exampl robot debat attend last tuesday even surgeon present
con posit said hard argu accuraci implant placement mako
anoth mako present attend friday present suggest even good surgeon
variat treatment outcom see less variat mako specif
surgeon suggest think could done better end tradit knee
replac case similar feel mako total knee replac
comment expect launch date next-gener mako robot surgeri
system contact continu suggest readi launch end moreov
continu believ next-gener mako robot surgeri system includ shoulder ankl
appear pois meaning market share gain hip implant segment follow
initi full roll-out trident ii tritanium acetabular system year aao meet
note seen strong hip market share gain behind signific product launch
accolad ii hip stem led bp world-wide hip market share gain new
trident hip cup launch seem like could similar opportun caveat may tougher
product gain similar attent time around given continu roll-out mako total
knee applic overal felt expect gain bp hip implant market share
year may conserv lieu opportun present trident ii tritanium acetabular
suggest segment trauma busi plan could pass market-lead
depuy synth notabl compani suggest see path market share trauma
medsurg equip syk feedback hospit capit spend trend remain posit product
cycl influenc expect categori note compani continu expect step-down
endoscopi organ growth rel low-double-digit increas enter year three
camera system instrument organ growth expect stronger given
compani still earli roll-out power surgic instrument
expect double-digit year-over-year growth product busi continu
rebound product suppli issu overal compani suggest recoveri
schedul slightli plan
expect obtain fda clearanc aspiration-bas thrombectomi system launch
product year end compani like third fourth market behind market leader
recent entrant said unclear much market effort put behind product
given view stent retriev better treatment option direct aspir acut ischem
stroke patient larg vessel occlus
expect growth emerg market busi total revenu good great
better year expect
call year oper margin leverag compani manag suggest
earli say compani could exceed formal guidanc bp adjust oper margin
expans year inclus dilut entellu acquisit seem like possibl
complet anoth dilut acquisit year along entellu compani would tri find
offset maintain ep outlook
adjust estim better reflect late februari time entellu acquisit
adjust ep forecast compani remain
consensu expect respect
snn highlight navio surgic system analyst event aao confer
compani would comment system placement estim navio annual revenu
million rang year-over-year growth growth base
roughli million snn call navio small contributor above-market
growth knee implant busi behind total knee partial knee applic compani
see opportun rapidli develop new applic use singl navio surgic
compani first market bicruci retain knee applic navio
simplifi technic demand procedur see opportun market reach
level partial knee replac time addit snn highlight knee revis
upcom opportun navio although like occur next month compani
also expect futur applic navio includ
arthroscopi trauma although timelin given program
cementless knee snn offer sever older knee implant system
journey ii compani expect launch cementless version journey ii next year
said snn abl gain market share knee busi recent period despit gap
product line
arthroscop enabl technolog snn think arthrex cnmd linvatec busi abl
convert custom rf system compet arthrocar busi snn acquir
follow entri categori snn seem hope move past worst
competit pressur categori although remain seen compani also see
competit pressur menisc repair
snn think market growth arthroscop enabl technolog posit low-single-digit rang
compani expect get back market growth level next quarter think
target exit year moreov think reach top end organ growth
guidanc depend turn around three segment weak enter year
advanc wound care advanc wound bioactiv arthroscop enabl technolog
research suggest snn roll regeneten bioactiv implant acquir decemb
rotat medic acquisit top sale territori march sens snn move
deliber launch make sure get right
contact orthoped contract manufactur market saw first indic vendor
consolid effort relat snn apex program late februari earli march
accord industri contact snn close hire casey next ceo prior decis
join januari heard stick point snn desir ceo base
london earn call last month question snn ceo search take
long think compani unsuccess pursuit casey like one reason
expect depuy synth busi contributor better organ growth perform
world-wide medic devic divis compani point number major medic
devic launch year includ half orthoped versu last year time
launch weight last year reason stronger outlook depuy synth
domest busi addit think hospit consolid increas use multi-
product line contract aid compani versu competitor specif compani indic
depuy synth sale part multi-seg contract
joint reconstruct appear count big year hip off-set expect
anoth year modest market share loss knee hip depuy initi gener launch
acti total hip system design specif use direct anterior approach
year aao annual meet led effort drive adopt direct anterior approach
market clearli appear move direct surgeon use approach
five year ago addit highlight sever newer enabl technolog hip
replac exhibit hall booth includ surgic impactor enabl mallet free
surgeri joint point hip navig technolog co-promot partnership
knee view attun revis knee system upcom attun cementless knee launch
relationship orthotaxi robot upcom growth driver attun revis knee system
began roll materi impact year gener launch
attun cementless knee expect late earli notabl knee revis point
entri larger fix bear segment market key opportun attun system
continu call industri discuss number earli revis due tibial loosen
attun primari knee system non-issu support registri data
one jnj competitor suggest step-up compani transit hybrid sale forc
direct rep may factor impact depuy weak knee implant sale growth
believ case
overal head year aao annual meet expect market share dynam larg hip
knee implant compani look similar robust market share gain slightli market-level
growth snn modestli market-level growth depuy continu soft result follow
academi meet think assumpt look direct correct anyth felt littl
pessimist zbh outlook modestli optimist syk prospect convers
smith nephew plcannual incom statement forecast adjust northcoast research million except percentag per share gross gross sg sg net interest incom financ result dispos net asset held profit incom tax incom margin incom margin adr wghd averag share adr adr revenu growth adjust ep growth compani report northcoast research estim
stryker corporationannu incom statement analysi adjust northcoast research million except percentag per share gross gross sg intang stock option expensesn/an/an/an/an/an/an/an/a oper oper net interest incom incom tax incom extra incom extra extra net net wghd com share ep ep growth ep growth start exclud acquistion-rel intang amort expens adjust ep compani report northcoast research estim
inc annual incom statement analysi adjust northcoast research million except percentag per share gross gross sg sg oper oper net interest incom net interest incom incom incom incom tax minor incom extra incom extra extra net net wghd com share ep ep growth ep growth exclud amort intang asset adjust ep start compani report northcoast research estim disclosur
